No Data
No Data
Enanta Pharmaceuticals(ENTA.US) Officer Sells US$89,589.78 in Common Stock
$Enanta Pharmaceuticals(ENTA.US)$ Officer Kieffer Tara Lynn sold 7,266 shares of common stock on Jun 17, 2024 at an average price of $12.33 for a total value of $89,589.78.Source: Announcement What is
Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
PDF Version WATERTOWN, Mass.--(BUSINESS WIRE)--May 29, 2024-- Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virolog
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) shareholders are probably feeling a little disappointed, since its shares fell 8.3% to US$12.76 in the week after its latest quarterly results. Revenue
Enanta Pharmaceuticals | 10-Q: Quarterly report
Hold Rating on Enanta Pharmaceuticals Amidst Clinical Trials Uncertainty and Financial Outlook
Enanta Pharmaceuticals Price Target Cut to $27.00/Share From $28.00 by HC Wainwright & Co.
Enanta Pharmaceuticals Price Target Cut to $27.00/Share From $28.00 by HC Wainwright & Co.